ID: ALA562422

Max Phase: Preclinical

Molecular Formula: C25H19N3O6S

Molecular Weight: 489.51

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(/C=C2/C(=O)NC(=S)N(c3ccccc3)C2=O)c(C)n1-c1cc(C(=O)O)cc(C(=O)O)c1

Standard InChI:  InChI=1S/C25H19N3O6S/c1-13-8-15(14(2)27(13)19-10-16(23(31)32)9-17(11-19)24(33)34)12-20-21(29)26-25(35)28(22(20)30)18-6-4-3-5-7-18/h3-12H,1-2H3,(H,31,32)(H,33,34)(H,26,29,35)/b20-12-

Standard InChI Key:  JQIGYUULGQKILM-NDENLUEZSA-N

Associated Targets(non-human)

UDP-N-acetylmuramate--L-alanine ligase 45 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase 77 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Enterococcus faecalis 29875 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Haemophilus influenzae 8812 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 489.51Molecular Weight (Monoisotopic): 489.0995AlogP: 3.32#Rotatable Bonds: 5
Polar Surface Area: 128.94Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.44CX Basic pKa: CX LogP: 4.23CX LogD: -2.58
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.28Np Likeness Score: -1.44

References

1. Perdih A, Kovac A, Wolber G, Blanot D, Gobec S, Solmajer T..  (2009)  Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach.,  19  (10): [PMID:19369074] [10.1016/j.bmcl.2009.03.141]
2. Perdih A, Hrast M, Barreteau H, Gobec S, Wolber G, Solmajer T..  (2014)  Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).,  22  (15): [PMID:24953950] [10.1016/j.bmc.2014.05.058]

Source